来凯医药-B现涨超5% 此前宣布与礼来达成全球临床合作协议

新浪港股
Dec 19, 2024
热点栏目 自选股 数据中心 行情中心 资金流向 模拟交易
客户端

  来凯医药-B(02105)盘中涨超13%,截至发稿,股价上涨5.12%,现报10.06港元,成交额1.115亿港元。

  今年11月,来凯医药发布公告称,公司与礼来达成全球临床合作协议,礼来将负责在美国开展一项针对来凯减肥药LAE102的Ⅰ期临床研究,并承担相关费用。

  长城证券此前指出,以增肌减脂药物LAE102为代表的自研管线具备良好创新前景,看好公司产品未来商业化发展。

海量资讯、精准解读,尽在新浪财经APP

责任编辑:卢昱君

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10